BLOG

Adieu 2020. Looking Forward to a saner 2021
News, PharmaBy Doron Aspitz, Verix CEO.
2020 is definitely not an easy year to summarize, neither personally nor professionally.
I have mixed feelings about this year. For Verix, the year that started with a feeling that a bombshell had been dropped on…

Unleashing the power of AI/ML by upskilling business users
Artificial Intelligence, Commercial OperationsThe emerging role of citizen data scientist in Pharma Commercial Operations.
Pharma and biotech companies, especially those introducing first-in-class Specialty & Oncology drugs, with added complexity such as novel mechanisms…

Why are so many AI projects doomed for failure?
Artificial Intelligence, Big DataThe elephant in the room is actually human
By Shahar Cohen, PhD, Head of Verix AI Lab. One of my first data science projects sought to improve the targeting process of a sales organization. Before we came in, sales reps were expected…

Bottom-up or Top-down Forecasting - Which Model Best Fits Your Needs?
Big Data, PharmaUnderstanding HCPs’ prescribing behavior Vs. analyzing market trends. Demand forecast is key for sales and operations planning in the pharmaceutical industry. Naturally, a lot of time, money, and effort are invested in developing forecast…

Turn red roses into red alerts- How to detect anomalies before they affect your business
Big Data, PharmaHave You Noticed There’s a Rosebush in Every Vineyard? Why and what can we learn from it? The picturesque 12th century Chateau Clos de Vougeot in Burgundy was famous for its prolific vineyards, maintained by local monks. These monks realized…

Data: The Unlikely Star in a New ADHD Drug Launch
Data Analytics, Press and News In the whirlwind months leading up to a drug launch, data is just one of many concerns on pharma companies’ minds. But even before a new treatment gets into the hands of patients, companies with the right kind of advanced analytics…

How to Ride the Data Wave When Launching a New Drug
Data Analytics, Press and News Some experts say that 50% of drug launches fail. Others say it’s as high as 90%. From my perspective, judging launches in such black-and-white terms isn’t particularly useful. Instead, I look at the market performance of a new drug…

Five different ways to tell your story
Data Analytics, Data Collaboration, Pharma Accessible and actionable data are two basic stepping-stones for efficient data analyses. However, in today’s working environments, these are not enough, and to create truly successful working conditions that drive business growth, data…

What comes first, the problem or the solution?
Business Intelligence, Data AnalyticsRather than spending months on requirements specifications followed by long, complicated implementations that by the time they’re ready to launch are already behind the eight ball, kick off a pilot initiative with the latest technology attainable…